Kanneganti Murthy

Inotek Pharmaceuticals Corporation

$5,565,701

Attributed

$5,565,701

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY2005–19

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$5,565,701 · 13

By mechanism

R43$3,087,997 · 11

R44$2,477,704 · 2

Top collaborators

No co-investigators on record.

Most similar at Inotek Pharmaceuticals Corporation

Same institution · by research overlap

Prakash Jagtap$6,029,479
Andrew L Salzman$19,918,828

Others in their field

Top investigators on “Innovation”

David R. Weir · University Of Michigan At Ann Arbor$382,307,654
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
Richard A Gibbs · Baylor College Of Medicine$300,634,418
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Judith S. Currier · University Of California Los Angeles$271,752,220

Research focus

InnovationProductionSafetyInjuryClinically RelevantInflammatoryTissuesDosePathway InteractionsPharmacologyPharmaceutical PreparationsInflammationT-LymphocyteSmall Business Innovation Research GrantToxicologyAnimalsFunctional DisorderAutoimmune DiseasesRelative (Related Person)AcuteControl GroupsPharmacodynamicsMediatingHistologic